Research News From June 29, 2011
advertisement
- Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial. See also ADA: Type 1 Diabetes Vaccine Fails to Show Benefit.
- Improvements in the Life Expectancy of Type 1 Diabetes: The Pittsburgh Epidemiology of Diabetes Complications Study. See also Life Expectancy Improves for Type 1 Diabetics.
- Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial. See also ADA: Biologic Slows Type 1 Diabetes.
- Uncoupling of Proliferation and Cytokines From Suppression Within the CD4+CD25+Foxp3+ T�Cell Compartment in the 1st Year of Human Type 1 Diabetes.
- ADA: FDA Artificial Pancreas Initiative InFocus.